| Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC (NCT00834158) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT01198704) | Assistance Publique - Hôpitaux de Paris | 2009-01-01 |
| Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC) (NCT00823290) | University of Erlangen-Nürnberg Medical School | 2009-01-01 |
| Sonazoid Enhanced Liver Cancer Trial for Early Detection (NCT00822991) | Kindai University | 2009-01-01 |
| Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma (NCT01157013) | Hospital Miguel Servet | 2009-01-01 |
| A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection (NCT00820053) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy (NCT00820339) | Eastern Hepatobiliary Surgery Hospital | 2009-01-01 |
| Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) (NCT00892658) | University Health Network, Toronto | 2009-01-01 |
| Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) (NCT00802555) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2009-01-01 |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma (NCT00827554) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels (NCT00814242) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence (NCT00817895) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection (NCT00825669) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT00805896) | Fudan University | 2008-12-01 |
| A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection (NCT00819650) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy (NCT00851968) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation (NCT01125020) | Shanghai Jiao Tong University School of Medicine | 2008-12-01 |
| Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma (NCT00828594) | Novartis Pharmaceuticals | 2008-12-01 |
| Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients (NCT00849264) | Eastern Hepatobiliary Surgery Hospital | 2008-12-01 |
| Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma (NCT01008358) | Clinica Universidad de Navarra, Universidad de Navarra | 2008-12-01 |
| LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed (NCT00877071) | University of Pittsburgh | 2008-11-01 |
| Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma (NCT00820157) | Eastern Hepatobiliary Surgery Hospital | 2008-11-01 |
| Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma (NCT00911196) | GlaxoSmithKline | 2008-11-01 |
| Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion (NCT00826384) | Eastern Hepatobiliary Surgery Hospital | 2008-10-01 |
| Comparison of Microwave and Radiofrequency Ablation for Liver (NCT02539212) | Chinese PLA General Hospital | 2008-10-01 |
| Study of Hepatocellular Carcinoma in Cirrhotic Patients (NCT01904942) | Centre Hospitalier Universitaire Dijon | 2008-10-01 |
| Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 (NCT00775073) | Gerhard Treiber | 2008-10-01 |
| Stereotactic Body Radiotherapy for Liver Tumors (NCT01347333) | Mercy Research | 2008-09-01 |
| Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT00768937) | Medical University of Vienna | 2008-09-01 |
| Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma (NCT00746590) | BTG International Inc. | 2008-09-01 |
| Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy (NCT00725335) | Southwest Hospital, China | 2008-09-01 |
| Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) (NCT00844688) | Combined Military Hospital, Pakistan | 2008-09-01 |
| Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy (NCT00687596) | Taiho Oncology, Inc. | 2008-08-01 |
| A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) (NCT01519232) | University of Michigan Rogel Cancer Center | 2008-08-01 |
| A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma (NCT00825474) | Eastern Hepatobiliary Surgery Hospital | 2008-08-01 |
| A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma (NCT00415155) | Eli Lilly and Company | 2008-08-01 |
| Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma (NCT01482520) | Samsung Medical Center | 2008-08-01 |
| Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (NCT00728078) | Sun Yat-sen University | 2008-07-01 |
| Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients (NCT00699816) | GC Cell Corporation | 2008-07-01 |
| A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (NCT00712855) | Human Genome Sciences Inc., a GSK Company | 2008-06-01 |
| Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer (NCT00769106) | Sun Yat-sen University | 2008-06-01 |
| Hepatocellular Carcinoma Growth and Molecular Aggressiveness (NCT01657695) | Prof. Facchinetti Fabio | 2008-06-01 |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (NCT00988195) | Bio-Cancer Treatment International Limited | 2008-05-01 |
| Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) (NCT00617981) | Imunon | 2008-05-01 |
| Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma (NCT00844454) | Sun Yat-sen University | 2008-05-01 |
| Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) (NCT00707681) | Microbio Co Ltd | 2008-03-01 |
| Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization (NCT00630240) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2008-02-01 |
| Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (NCT00562666) | Rennes University Hospital | 2008-02-01 |
| Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy (NCT00627042) | Eli Lilly and Company | 2008-02-01 |
| Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication (NCT00769730) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2008-01-01 |
| HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC (NCT00605150) | Wake Forest University Health Sciences | 2008-01-01 |
| TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (NCT00618384) | Heinrich-Heine University, Duesseldorf | 2008-01-01 |
| The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma (NCT00838968) | Fudan University | 2008-01-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant (NCT06233708) | Asan Medical Center | 2008-01-01 |
| A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark (NCT00902902) | Peking Union Medical College Hospital | 2008-01-01 |
| Mutational Landscape in Hepatocellular Carcinoma (NCT03071458) | Institut National de la Santé Et de la Recherche Médicale, France | 2008-01-01 |
| Long-term Management of Patients With Ruptured HCC (NCT06505291) | University Hospital, Caen | 2008-01-01 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (NCT00568308) | Progen Pharmaceuticals | 2007-12-01 |
| Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC (NCT00606385) | Seoul National University Hospital | 2007-12-01 |
| Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients (NCT00644020) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2007-12-01 |
| Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (NCT00557024) | Sun Yat-sen University | 2007-11-01 |
| Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (NCT00555334) | Sun Yat-sen University | 2007-11-01 |
| Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma (NCT00539643) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection (NCT00561522) | Fudan University | 2007-11-01 |
| TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma (NCT00556803) | Sun Yat-sen University | 2007-11-01 |
| Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma (NCT00522405) | All India Institute of Medical Sciences | 2007-10-01 |
| TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma (NCT01349075) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2007-10-01 |
| Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. (NCT00539253) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-09-01 |
| Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression (NCT00797251) | University of Milan | 2007-09-01 |
| A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma (NCT00524498) | Otsuka Pharmaceutical Co., Ltd. | 2007-09-01 |
| RAD001 in Advanced Hepatocellular Carcinoma (NCT00516165) | Massachusetts General Hospital | 2007-08-01 |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients (NCT00526617) | AbbVie | 2007-08-01 |
| Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) (NCT00914355) | University Health Network, Toronto | 2007-08-01 |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers (NCT00832637) | New Mexico Cancer Research Alliance | 2007-08-01 |
| Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria (NCT00554125) | Fudan University | 2007-08-01 |
| Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study (NCT00493428) | University of Manitoba | 2007-07-01 |
| Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma (NCT00493402) | Sun Yat-sen University | 2007-07-01 |
| A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. (NCT00428220) | Pfizer | 2007-07-01 |
| Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma (NCT01277653) | Yonsei University | 2007-06-01 |
| Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma (NCT00467974) | Chinese University of Hong Kong | 2007-06-01 |
| Sorafenib With TACE to Treat Hepatocellular Carcinoma (NCT00478374) | University of Bern | 2007-05-01 |
| A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma (NCT00455091) | National Health Research Institutes, Taiwan | 2007-05-01 |
| Intravascular Ultrasound for Hepatocellular Carcinoma Staging (NCT00474734) | University Hospital, Geneva | 2007-05-01 |
| Proton Therapy and Bevacizumab for Primary Liver Tumors (NCT00426829) | M.D. Anderson Cancer Center | 2007-05-01 |
| Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life (NCT00945568) | Kochi University | 2007-05-01 |
| The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment (NCT04299919) | The First Affiliated Hospital of Dalian Medical University | 2007-04-01 |
| Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) (NCT00464919) | National Taiwan University Hospital | 2007-04-01 |
| Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis (NCT00518557) | Southeast University, China | 2007-04-01 |
| Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma (NCT00768157) | Sun Yat-sen University | 2007-04-01 |
| Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 (NCT00405873) | Auron Healthcare GmbH | 2007-03-01 |
| Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma (NCT01266707) | Fukushima Medical University | 2007-03-01 |
| Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization (NCT00834028) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2007-02-01 |
| Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) (NCT00923897) | University Health Network, Toronto | 2007-02-01 |
| Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma (NCT00460681) | Fudan University | 2007-02-01 |
| A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver (NCT00441376) | Imunon | 2007-02-01 |
| Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC) (NCT01837381) | Chinese University of Hong Kong | 2007-02-01 |
| A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma (NCT00423306) | Alaunos Therapeutics | 2007-01-01 |
| Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease (NCT00629668) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2007-01-01 |
| Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach (NCT00829335) | University of Milan | 2007-01-01 |